The National Institutes of Health criteria for classification and scoring of chronic graft versus host disease: long-term follow-up of a single center series

References

• Lee SJ. Have we made progress in the management of chronic graft-vs-host disease? Best Pract Res Clin Haematol 2010;23:529–535.
   PubMed Web of Science ®Google Scholar
• Jagasia M, Schulman HM, Filipovich AH, . Diagnosis and staging. In: Vogelsang GB, Pavletic SZ, editors. Chronic graft versus host disease. Cambridge, UK: Cambridge University Press; 2009. pp. 87–100.
   Google Scholar
• Socié G. The NIH consensus criteria for chronic graft-versus-host disease: far more than just another classification. Leukemia 2009;23:1–2.
   PubMed Web of Science ®Google Scholar
• Sullivan KM, Weiden PL, Storb R, . Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 1989;73:1720–1728.
   PubMed Web of Science ®Google Scholar
• Shulman HM, Sullivan KM, Weiden PL, . Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204–217.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003;9:215–233.
   PubMed Web of Science ®Google Scholar
• Mielcarek M, Martin PJ, Leisenring W, . Graft-versus-host disease after nonmyeloablative versus conventional haematopoietic stem cell transplantation. Blood 2003;102:756–762.
   PubMed Web of Science ®Google Scholar
• Filipovich AH, Weisdorf D, Pavletic S, . National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005;11:945–956.
   PubMed Web of Science ®Google Scholar
• Jagasia M, Giglia J, Chinratanalab W, . Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria. Biol Blood Marrow Transplant 2007;13:1207–1215.
   PubMed Web of Science ®Google Scholar
• Pérez-Simón JA, Encinas C, Silva F, . Prognostic factors of chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation: the National Institute Health scale plus the type of onset can predict survival rates and the duration of immunosuppressive therapy. Biol Blood Marrow Transplant 2008;14:1163–1171.
   PubMed Web of Science ®Google Scholar
• Arora M, Nagaraj S, Witte J, . New classification of chronic GVHD: added clarity from the consensus diagnoses. Bone Marrow Transplant 2009;43:149–153.
   PubMed Web of Science ®Google Scholar
• Cho BS, Min CK, Eom KS, . Feasibility of NIH consensus criteria for chronic graft-versus-host disease. Leukemia 2009;23:78–84.
   PubMed Web of Science ®Google Scholar
• Vigorito AC, Campregher PV, Storer BE, . National Institutes of Health. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood 2009;114:702–708.
   PubMed Web of Science ®Google Scholar
• Kim DY, Lee JH, Lee JH, . Reevaluation of the National Institutes of Health criteria for classification and scoring of chronic GVHD. Bone Marrow Transplant 2010;45:1174–1180.
   PubMed Web of Science ®Google Scholar
• Thepot S, Zhou J, Perrot A, . The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation. Leukemia 2010;24:1852–1858.
   PubMed Web of Science ®Google Scholar
• Sato T, Ichinohe T, Kanda J, . Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria. Int J Hematol 2011;93:532–541.
   PubMed Web of Science ®Google Scholar
• Pidala J, Kim J, Anasetti C, . The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality. Haematologica 2011;96:1678–1684.
   PubMed Web of Science ®Google Scholar
• Kuzmina Z, Eder S, Bohm A, . Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study. Leukemia 2012;26:746–756.
   PubMed Web of Science ®Google Scholar
• Arai S, Jagasia M, Storer B, . Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria. Blood 2011;118:4242–4249.
   PubMed Web of Science ®Google Scholar
• Glucksberg H, Storb R, Fefer A. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA matched sibling donors. Transplantation 1974;18:295–304.
   PubMed Web of Science ®Google Scholar
• Pepe MS, Mori M. Marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 1993;12: 737–751.
   PubMed Web of Science ®Google Scholar
• Cleves M, Gould W, Gutierrez R, . An introduction to survival analysis using Stata. College Station, TX: Stata Press; 2010.
   Google Scholar
• Lunn M, McNeil DR. Applying Cox regression to competing risks. Biometrics 1995;51:524–532.
   PubMed Web of Science ®Google Scholar
• Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med 2007;26:2389–2430.
   PubMed Web of Science ®Google Scholar
• Inamoto Y, Flowers ME, Lee SJ, . Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation. Blood 2011;118:456–463.
   PubMed Web of Science ®Google Scholar
• Cho BS, Lee SE, Song HH, . Graft-versus-tumor effect according to type of graft versus host disease defined by National Institutes of Health consensus criteria and associated outcomes. Biol Blood Marrow Transplant 2012;7:1136–1143.
   Web of Science ®Google Scholar
• Chronic GVHD Consortium. Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD. Biol Blood Marrow Transplant 2011;17:1114–1120.
   PubMed Web of Science ®Google Scholar